Here are some of the past week’s top stories on Healio.com/OSN:
DE-128 microshunt reduced IOP, medications in study
A multicenter study found the DE-128 microshunt implanted intraoperatively with 0.2 mg/mL concentration of mitomycin C effectively reduced IOP in patients with primary open-angle glaucoma not controlled with maximum tolerated glaucoma medications. Read more.
Values over value: what the new workforce wants
One remarkable difference between younger aged workers and their baby boomer counterparts is that Generation Z and millennial workers will quit a job if their
Uncategorized